HIV,AIDS,and the Respiratory Care Practitioner

Goldsmith MF . 'Critical moment' at hand in HIV/AIDS pandemic: new global strategy to arrest its spread proposed. JAMA 1992;268:445–446.

Farizo KM , Buehler JW , Chamberland ME , Whyte BM , Froelicher ES , Hopkins SG , . Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992;267:1798–1805.

Menitove JE . The decreasing risk of transfusion-associated AIDS (editorial). N Engl J Med 1989;321:966–968.

Gayle HD , Keeling RP , Garcia-Tunon M , Kilbourne BW , Narkunas JP , Ingram FR , . Prevalence of the human immunodeficiency virus among university students. N Engl J Med 1990;323:1538–1541.

Lifson AR . Current issues concerning the epidemiology of acquired immunodeficiency syndrome and human immunodeficiency virus. West J Med 1992;156:52–56.

St Louis ME , Conway GA , Hayman CR , Miller C , Petersen LR , Dondero TJ . Human immunodeficiency virus infection in disadvantaged adolescents: findings from the U.S. Job Corps. JAMA 1991;266:2387–2391.

Torres RA , Mani S , Altholz J , Brickner PW . Human immunodeficiency virus infection among homeless men in a New York City shelter: association with Mycobacterium tuberculosis infection. Arch Intern Med 1990;150:2030–2036.

Singleton JA , Perkins CI , Trachtenberg AI , Hughes MJ , Kizer KW , Ascher M. HIV antibody seroprevalence among prisoners entering the California correctional system. West J Med 1990;153:394–399.

St Louis ME , Rauch KJ , Petersen LR , Anderson JE , Schable CA , Dondero TJ . Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. N Engl J Med 1990;323:213–218.

Kelen GD , Fritz S , Qaqish B , Brookmeyer R , Baker JL , Kline RL , . Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med 1988;318:1645–1650.

Quinn TC , Glasser D , Cannon RO , Matuszak DL , Dunning RW , Kline RL , . Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med 1988;318:197–202.

Kelen GD , Green GB , Purcell RH , Chan DW , Qaqish BF , Sivertson KT , . Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 1992;326:1399–1404.

Price RW , Brew B , Sidtis J , Rosenblum M , Scheck AC , Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586–592.

Ho DD , Pomerantz RJ , Kaplan JC . Pathogenesis of infection with human immunodeficiency virus. N Engl J Med 1987;317:278–286.

Volberding PA , Lagakos SW , Koch MA , Pettinelli C , Myers MW , Booth DK , , and the AIDS Clinical Trial Group of the National Institute of Allergy and Infectious Diseases. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990;322:941–949.

Vella S , Giuliano M , Pezzotti P , Agresti MG , Tomino C , Floridia M , , and the Italian Zidovudine Evaluation Group. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. JAMA 1992;267:1232–1236.

Kahn JO , Lagakos SW , Richman DD , Cross A , Pettinelli C , Liou SH , , and the NIAID AIDS Clinical Trials Group. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med 1992;327:581–587.

Fischl MA , Dickinson GM , La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988;259:1185–1189.

Leoung GS , Feigal DW Jr , Montgomery AB , Corkery K , Wardlaw L , Adams M , . Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia: the San Francisco Community Prophylaxis Trial. N Engl J Med 1990;323:769–775.

Martin MA , Cox PH , Beck K , Styer CM , Beall GN . A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med 1992;152:523–528.

Sattler FR , Cowan R , Nielsen DM , Ruskin J. Trimethoprimsulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective, noncrossover study. Ann Intern Med 1988;109:280–287.

Montgomery AB , Debs RJ , Luce JM , Corkery KJ , Turner J , Brunette EN , . Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet 1987;2:480–483.

Montgomery AB , Edison RE , Sattler F , Hopewell P , Mason G , Feigal DW , and the Aerosolized Pentamidine Study Group. Aerosolized pentamidine vs trimethoprim/sulfamethox-azole for acute Pneumocystis carinii pneumonia (PCP): a randomized double-blind trial (abstract). Proceedings of the Sixth International Conference on AIDS. Florence, Italy: 1990 Th B 395.

Gagnon S , Boota A , Fischl MA , Baier H , Kirksey DW , La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1444–1450.

Murray JF . The white plague: down and out, or up and coming? Am Rev Respir Dis 1989;140:1788–1795.

Selwyn PA , Hartel D , Lewis VA , Schoenbaum EE , Vermund SH , Klein RS , . A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl J Med 1989;320:545–550.

Daley CL , Small PM , Schecter GF , Schoolnik GK , McAdam RA , Jacobs WR Jr , . An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992;326:231–236.

Hopewell PC . Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis 1992;15:540–547.

Hopewell PC . Tuberculosis and human immunodeficiency virus infection. Semin Respir Infect 1989;4:111–122.

Small PM , Schecter GF , Goodman PC , Sande MA , Chaisson RE , Hopewell PC . Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991;324:289–294.

Brudney K , Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745–749.

Edlin BR , Tokars JI , Grieco MH , Crawford JT , Williams J , Sordillo EM , . An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514–1521.

Beck-Sague C , Dooley SW , Hutton MD , Otten J , Breeden A , Crawford JT , . Hospital outbreak of multidrug-resistant Mycobacteriurm tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280–1286.

Busillo CP , Lessnau KD , Sanjana V , Soumakis S , Davidson M , Mullen MP , . Multidrug resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest 1992;102:797–801.

Marcus R. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. N Engl J Med 1988;319:1118–1123.

Salpeter S. Tuberculosis chemoprophylaxis. West J Med 1992;157:421–424.

Gerberding JL . Recommended infection-control policies for patients with human immunodeficiency virus infection: an update. N Engl J Med 1986;315:1562–1564.